Showing results (531-540 of 596) with videos related to

Sort By:
Pageof 60
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Hyperactivity and impaired response habituation in hyperdopaminergic miceX Zhuang, R S Oosting, S R Jones, et al.
Translational Psychiatry|August 15, 2013
The effects of congenital brain serotonin deficiency on responses to chronic fluoxetineB D Sachs, J P R Jacobsen, T L Thomas, et al.
The Journal of Comparative Neurology|June 17, 1996
Ontogeny of the striatal neurons expressing the D1 dopamine receptor in humansC Brana, I Caille, C Pellevoisin, et al.
Trends in Pharmacological Sciences|June 1, 1990
Dopamine receptor subtypes: beyond the D1/D2 classificationP H Andersen, J A Gingrich, M D Bates, et al.
Neuron|July 1, 1997
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporterR Bossé, F Fumagalli, M Jaber, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor functionG R King, E H Ellinwood, C Silvia, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating proteinR T Premont, A Claing, N Vitale, et al.
Circulation Research|January 23, 1999
Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytesR P Xiao, P Avdonin, Y Y Zhou, et al.
Biochemistry|May 31, 1988
Affinity chromatography of the D1 dopamine receptor from rat corpus striatumJ A Gingrich, N Amlaiky, S E Senogles, et al.
Journal of Neurochemistry|May 8, 1998
Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout miceR R Gainetdinov, F Fumagalli, Y M Wang, et al.
Pageof 60